Physician profile
Kyle T Pearson
NPI 1780971598
$207,534.38
in general payments reported to CMS, 2019-2025
24 companies · $38K in 2025
The $38K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $22K · 2021: $25K · 2022: $25K · 2023: $27K · 2024: $33K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $81K · Travel and Lodging: $11K · Food and Beverage: $5,631 · Education: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $80,625.00 |
| Travel and Lodging | $11,484.33 |
| Food and Beverage | $5,631.04 |
| Education | $151.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $188,960.39 | 2019-2025 | Ortholoc 2 Lapifuse, Hoffmann, Inbone |
| Misonix INC | $11,726.07 | 2019-2020 | |
| Medical Device Business Services, INC. | $4,277.83 | 2019 | |
| Restor3d, INC. | $905.55 | 2024 | |
| Integra Lifesciences Corporation | $470.75 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $274.64 | 2019-2020 | |
| Smith+Nephew, INC. | $127.74 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System, Stravix |
| Biogennix, LLC | $123.09 | 2023 | Agilon |
| Pacira Therapeutics, INC. | $118.12 | 2019-2021 | |
| Organogenesis INC. | $95.10 | 2021-2023 | Puraply |
| Zimmer Biomet Holdings, INC. | $73.42 | 2020 | |
| Kerecis Limited | $62.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ossio INC | $41.62 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $37.84 | 2025 | |
| Merck Sharp & Dohme LLC | $36.95 | 2024-2025 | Bridion |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $35.72 | 2023-2025 | Cmf |
| Pacira Pharmaceuticals Incorporated | $34.68 | 2021 | |
| Sanofi-Aventis U.S. LLC | $30.32 | 2019-2023 | |
| Bioventus LLC | $27.04 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Convatec INC. | $17.90 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.10 | 2021 | |
| Horizon Therapeutics Plc | $14.94 | 2021 | |
| Tactile Systems Technology INC | $13.55 | 2021 | |
| Osiris Therapeutics INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.